Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals - 34 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Regeneron Pharmaceuticals as of June 09, 2025 is 517.60.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 1198.45 on August 27, 2024.
  • The Regeneron Pharmaceuticals 52-week high stock price is 1211.20, which is 134% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 476.49, which is 7.9% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 831.12.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 634.1274 713.2180 743.7310 483.0700 517.6000 -27.14%
2024 965.6237 902.5050 1198.4500 699.9150 710.3660 -18.90%
2023 781.6642 718.4840 879.2690 678.6140 875.8690 21.73%
2022 660.6900 625.3710 764.2770 546.8380 719.5010 14.25%
2021 556.7856 481.5290 679.0830 445.4990 629.7790 30.72%
2020 530.8904 372.3210 656.3960 335.2530 481.7780 28.66%
2019 342.5594 371.4130 438.3580 272.7060 374.4450 0.53%
2018 350.6986 381.5450 407.3840 283.8150 372.4700 -0.65%
2017 421.3183 378.6530 525.0780 339.8110 374.9240 2.42%
2016 393.4125 515.1260 518.0480 330.1370 366.0780 -32.38%
2015 497.3582 409.0290 590.7670 395.7960 541.3730 32.33%
2014 332.7478 273.8330 433.7510 266.8820 409.1190 49.05%
2013 239.2000 180.7010 315.7570 157.9830 274.4810 60.89%
2012 130.4733 56.2744 187.2230 56.2744 170.5980 208.62%
2011 50.9658 33.7268 71.9910 32.5201 55.2772 68.84%
2010 26.1406 24.5621 33.5971 20.7327 32.7395 35.77%
2009 17.6683 18.6484 24.6718 12.0168 24.1133 31.70%
2008 18.9271 23.4951 24.7017 13.3132 18.3094 -23.98%
2007 20.4928 19.7554 28.5212 13.6223 24.0834 20.33%
2006 16.0708 15.8562 24.2131 11.0893 20.0147 26.23%
2005 8.2753 9.0151 16.7836 4.6172 15.8562 72.64%
2004 10.8053 15.0085 16.6739 6.8311 9.1846 -37.39%
2003 14.7150 19.0374 22.2485 5.8638 14.6694 -20.53%
2002 18.8325 27.8430 29.2292 11.3287 18.4590 -34.27%
2001 28.2992 35.4645 38.8925 20.5432 28.0824 -20.15%
2000 27.2595 12.2786 56.3442 11.4683 35.1684 176.59%
1999 7.7957 7.9156 12.7149 5.5472 12.7149 72.88%
1998 8.1252 8.8505 10.9073 5.8588 7.3547 -13.87%
1997 9.8584 17.0778 19.3216 6.4821 8.5389 -46.90%
1996 16.2180 13.2135 24.5571 11.8423 16.0805 26.47%
1995 9.5748 3.3034 16.4545 3.3034 12.7149 325.01%
1994 7.0163 15.2080 17.2024 2.9917 2.9917 -80.65%
1993 15.4592 11.9669 21.4407 10.9697 15.4573 29.17%
1992 12.9828 18.6983 22.4380 7.9779 11.9669 -33.79%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $53.251B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $226.021B 16.87
Amgen (AMGN) United States $156.112B 13.98
Gilead Sciences (GILD) United States $139.892B 14.53
Vertex Pharmaceuticals (VRTX) United States $115.687B 0.00
Bristol Myers Squibb (BMY) United States $98.518B 6.60
GSK (GSK) United Kingdom $84.443B 10.10
CSL (CSLLY) Australia $76.467B 0.00
Alnylam Pharmaceuticals (ALNY) United States $39.225B 0.00
Argenex SE (ARGX) Netherlands $35.777B 97.65
BioNTech SE (BNTX) Germany $26.080B 0.00
Biogen (BIIB) United States $19.507B 8.42
Royalty Pharma (RPRX) United States $18.992B 8.02
Genmab (GNMSF) Denmark $14.413B 14.74
Genmab (GMAB) Denmark $14.235B 15.97
Insmed (INSM) United States $13.409B 0.00
Incyte (INCY) United States $13.312B 101.13
Illumina (ILMN) United States $13.085B 24.82
Exelixis (EXEL) United States $11.735B 19.92
BioMarin Pharmaceutical (BMRN) United States $10.864B 17.65
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Moderna (MRNA) United States $10.620B 0.00
Ascendis Pharma (ASND) Denmark $10.572B 0.00
Exact Sciences (EXAS) United States $10.351B 0.00
QIAGEN (QGEN) Netherlands $10.110B 19.67
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.925B 0.00
Blueprint Medicines (BPMC) United States $8.257B 0.00
Revolution Medicines (RVMD) United States $7.654B 0.00
Roivant Sciences (ROIV) United Kingdom $7.634B 0.00
Bio-Techne Corp (TECH) United States $7.633B 28.47
Repligen (RGEN) United States $7.208B 80.69
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.180B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.851B 6.60
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.685B 12.80
Legend Biotech (LEGN) United States $6.432B 0.00
TG Therapeutics (TGTX) United States $6.360B 166.92
Guardant Health (GH) United States $5.954B 0.00
Telix Pharmaceuticals (TLX) Australia $5.670B 0.00
Nuvalent (NUVL) United States $5.603B 0.00
Axsome Therapeutics (AXSM) United States $5.510B 0.00
Alkermes (ALKS) Ireland $5.229B 14.03
Zealand Pharma (ZLDPF) Denmark $5.051B 0.00
ADMA Biologics Inc (ADMA) United States $4.920B 36.80
Vaxcyte (PCVX) United States $4.772B 0.00
Avidity Biosciences (RNA) United States $4.368B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.333B 0.00
Akero Therapeutics (AKRO) United States $4.327B 0.00
Sarepta Therapeutics (SRPT) United States $4.227B 0.00
Zai Lab (ZLAB) China $4.205B 0.00
PTC Therapeutics (PTCT) United States $4.132B 7.19
Krystal Biotech (KRYS) United States $3.957B 30.50
Merus (MRUS) Netherlands $3.891B 0.00
Cytokinetics (CYTK) United States $3.858B 0.00
Arcellx (ACLX) United States $3.753B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.679B 32.32
CRISPR Therapeutics AG (CRSP) Switzerland $3.615B 0.00
SpringWorks Therapeutics (SWTX) United States $3.526B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.514B 0.00
Protagonist Therapeutics (PTGX) United States $3.371B 72.51
Scholar Rock Holding (SRRK) United States $3.250B 0.00
Alvotech (ALVO) Luxembourg $3.214B 18.38
Viking Therapeutics (VKTX) United States $3.126B 0.00
Kymera Therapeutics (KYMR) United States $3.101B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.001B 0.00
Metsera (MTSR) United States $2.888B 0.00
Immunovant (IMVT) United States $2.866B 0.00
ImmunityBio (IBRX) United States $2.780B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.676B 0.00
Ascentage Pharma Group - (AAPG) China $2.472B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.428B 0.00
Apellis Pharmaceuticals (APLS) United States $2.423B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.321B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.297B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.206B 0.00
Vericel (VCEL) United States $2.180B 1443.33
Bavarian Nordic (BVNRY) Denmark $2.168B 11.46
Denali Therapeutics (DNLI) United States $2.136B 0.00
CG Oncology (CGON) United States $2.051B 0.00
Ligand Pharmaceuticals (LGND) United States $2.045B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.044B 13.59
Agios Pharmaceuticals (AGIO) United States $1.988B 0.00
Certara (CERT) United States $1.908B 35.64
IDEAYA Biosciences (IDYA) United States $1.903B 0.00
Belite Bio (BLTE) United States $1.900B 0.00
Amicus Therapeutics (FOLD) United States $1.897B 205.33
NovoCure (NVCR) Jersey $1.895B 0.00
Twist Bioscience (TWST) United States $1.892B 0.00
Apogee Therapeutics (APGE) United States $1.887B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.871B 0.00
Beam Therapeutics (BEAM) United States $1.868B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.845B 0.00
Biohaven (BHVN) United States $1.739B 0.00
Disc Medicine (IRON) United States $1.732B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.713B 0.00
Edgewise Therapeutics (EWTX) United States $1.603B 0.00
Janux Therapeutics (JANX) United States $1.551B 0.00
Liquidia Technologies (LQDA) United States $1.551B 0.00
Adaptive Biotechnologies (ADPT) United States $1.533B 0.00
Mesoblast (MESO) Australia $1.507B 0.00
89BIO (ETNB) United States $1.496B 0.00
Vera Therapeutics (VERA) United States $1.448B 0.00
Celldex Therapeutics (CLDX) United States $1.417B 0.00
GRAIL (GRAL) United States $1.380B 0.00
Travere Therapeutics (TVTX) United States $1.360B 0.00
ANI Pharmaceuticals (ANIP) United States $1.342B 13.83
MannKind (MNKD) United States $1.331B 27.38
BGM Group (BGM) China $1.272B 0.00
Anbio Biotechnology (NNNN) Germany $1.233B 0.00
Dynavax Technologies (DVAX) United States $1.230B 73.14
Structure Therapeutics (GPCR) United States $1.212B 0.00
Novavax (NVAX) United States $1.207B 2.81
Pacira BioSciences (PCRX) United States $1.202B 11.44
Viridian Therapeutics (VRDN) United States $1.198B 0.00
WAVE Life Sciences (WVE) Singapore $1.113B 0.00
Arcus Biosciences (RCUS) United States $1.056B 0.00
Mineralys Therapeutics (MLYS) United States $1.051B 0.00
Spyre Therapeutics (SYRE) United States $1.023B 0.00
Niagen Bioscience (NAGE) United States $1.020B 143.89
Geron (GERN) United States $1.019B 0.00
CureVac (CVAC) Germany $0.989B 4.79
Syndax Pharmaceuticals (SNDX) United States $0.985B 0.00
Nurix Therapeutics (NRIX) United States $0.974B 0.00
MiMedx (MDXG) United States $0.959B 23.18
NeoGenomics (NEO) United States $0.955B 0.00
CorMedix Inc (CRMD) United States $0.948B 63.54
UniQure (QURE) Netherlands $0.946B 0.00
Praxis Precision Medicines (PRAX) United States $0.908B 0.00
LENZ Therapeutics (LENZ) United States $0.900B 0.00
Pharvaris (PHVS) Netherlands $0.877B 0.00
Zymeworks (ZYME) United States $0.877B 0.00
Oculis Holding AG (OCS) Switzerland $0.870B 0.00
Nuvation Bio (NUVB) United States $0.844B 0.00
Intellia Therapeutics (NTLA) United States $0.838B 0.00
Trevi Therapeutics (TRVI) United States $0.828B 0.00
Pharming Group (PHAR) Netherlands $0.807B 0.00
ArriVent BioPharma (AVBP) United States $0.805B 0.00
Replimune (REPL) United States $0.800B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Immunome (IMNM) United States $0.794B 0.00
Gyre Therapeutics (GYRE) United States $0.789B 210.25
Cogent Biosciences (COGT) United States $0.774B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Sionna Therapeutics (SION) United States $0.760B 0.00
Vir Biotechnology (VIR) United States $0.753B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.729B 0.00
AbCellera Biologics (ABCL) Canada $0.728B 0.00
Immatics (IMTX) Germany $0.726B 0.00
Anavex Life Sciences (AVXL) United States $0.706B 0.00
AnaptysBio (ANAB) United States $0.696B 0.00
Iovance Biotherapeutics (IOVA) United States $0.685B 0.00
Arbutus Biopharma (ABUS) United States $0.667B 0.00
Oric Pharmaceuticals (ORIC) United States $0.663B 0.00
GH Research (GHRS) Ireland $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Sana Biotechnology (SANA) United States $0.640B 0.00
Bicara Therapeutics (BCAX) United States $0.627B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.623B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.623B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.615B 0.00
Keros Therapeutics (KROS) United States $0.611B 0.00
Stoke Therapeutics (STOK) United States $0.608B 14.10
Upstream Bio (UPB) United States $0.606B 0.00
Dianthus Therapeutics (DNTH) United States $0.606B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.592B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.589B 0.00
Kura Oncology (KURA) United States $0.583B 0.00
Maze Therapeutics (MAZE) United States $0.566B 0.00
Tyra Biosciences (TYRA) United States $0.560B 0.00
Arvinas (ARVN) United States $0.550B 0.00
Cullinan Therapeutics (CGEM) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Abivax SA (ABVX) France $0.520B 0.00
Castle Biosciences (CSTL) United States $0.508B 34.51
Celcuity (CELC) United States $0.494B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
MeiraGTx Holdings (MGTX) United States $0.482B 0.00
REGENXBIO (RGNX) United States $0.482B 0.00
ATyr Pharma (ATYR) United States $0.479B 0.00
Fortrea Holdings (FTRE) United States $0.478B 13.20
Myriad Genetics (MYGN) United States $0.469B 0.00
Zenas BioPharma (ZBIO) United States $0.465B 0.00
Rapport Therapeutics (RAPP) United States $0.462B 0.00
Tango Therapeutics (TNGX) United States $0.462B 0.00
PureTech Health (PRTC) United States $0.456B 0.00
Septerna (SEPN) United States $0.455B 0.00
Erasca (ERAS) United States $0.453B 0.00
Eton Pharmaceuticals (ETON) United States $0.452B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.444B 0.00
Precigen (PGEN) United States $0.443B 0.00
Cytek Biosciences (CTKB) United States $0.436B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.436B 0.00
Tectonic Therapeutic (TECX) United States $0.431B 0.00
Sage Therapeutics (SAGE) United States $0.429B 0.00
Benitec Biopharma (BNTC) United States $0.420B 0.00
Humacyte (HUMA) United States $0.402B 0.00
Kamada (KMDA) Israel $0.394B 23.62
Northwest Biotherapeutics (NWBO) United States $0.392B 0.00
Fulcrum Therapeutics (FULC) United States $0.391B 0.00
ITeos Therapeutics (ITOS) United States $0.389B 0.00
Absci (ABSI) United States $0.387B 0.00
MBX Biosciences (MBX) United States $0.380B 0.00
Rezolute (RZLT) United States $0.379B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.364B 0.00
Emergent Biosolutions (EBS) United States $0.360B 0.00
Verastem (VSTM) United States $0.353B 0.00
Solid Biosciences (SLDB) United States $0.352B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.347B 0.00
Compass Therapeutics (CMPX) United States $0.346B 0.00
Inventiva S.A (IVA) France $0.345B 0.00
Abeona Therapeutics (ABEO) United States $0.345B 0.00
Urogen Pharma (URGN) United States $0.340B 0.00
Astria Therapeutics (ATXS) United States $0.338B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.327B 0.00
Aura Biosciences (AURA) United States $0.327B 0.00
Terns Pharmaceuticals (TERN) United States $0.323B 0.00
Alpha Teknova (TKNO) United States $0.317B 0.00
Cidara Therapeutics (CDTX) United States $0.316B 0.00
Entrada Therapeutics (TRDA) United States $0.316B 10.27
Neurogene (NGNE) United States $0.311B 0.00
Allogene Therapeutics (ALLO) United States $0.311B 0.00
Ocugen (OCGN) United States $0.310B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.308B 62.62
Olema Pharmaceuticals (OLMA) United States $0.305B 0.00
Candel Therapeutics (CADL) United States $0.303B 0.00
Gossamer Bio (GOSS) United States $0.302B 0.00
XOMA Royalty (XOMA) United States $0.302B 0.00
Prothena (PRTA) Ireland $0.291B 0.00
Cartesian Therapeutics (RNAC) United States $0.286B 0.00
Annexon (ANNX) United States $0.285B 0.00
Palvella Therapeutics (PVLA) United States $0.281B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.279B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.277B 0.00
Atea Pharmaceuticals (AVIR) United States $0.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.272B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Tvardi Therapeutics (TVRD) United States $0.267B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Amarin (AMRN) Ireland $0.263B 0.00
Semper Paratus Acquisition (TVGN) United States $0.263B 0.00
Cardiff Oncology (CRDF) United States $0.258B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Aardvark Therapeutics (AARD) United States $0.256B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
DBV Technologies S.A (DBVT) France $0.250B 0.00
Foghorn Therapeutics (FHTX) United States $0.249B 0.00
Third Harmonic Bio (THRD) United States $0.239B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.239B 0.00
BioStem Technologies (BSEM) $0.237B 9.64
Adherex Technologies (FENC) United States $0.233B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
MaxCyte (MXCT) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
Monopar Therapeutics (MNPR) United States $0.227B 0.00
Kodiak Sciences (KOD) United States $0.223B 0.00
Prime Medicine (PRME) United States $0.222B 0.00
ScPharmaceuticals (SCPH) United States $0.222B 0.00
CARGO Therapeutics (CRGX) United States $0.219B 0.00
Instil Bio (TIL) United States $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
CytomX Therapeutics (CTMX) United States $0.213B 5.50
AC Immune (ACIU) Switzerland $0.205B 0.00
Inhibrx Biosciences (INBX) United States $0.202B 0.12
GENFIT S.A (GNFT) France $0.201B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.201B 0.00
I-Mab (IMAB) United States $0.200B 0.00
Innate Pharma S.A (IPHA) France $0.200B 0.00
Codexis (CDXS) United States $0.196B 0.00
Voyager Therapeutics (VYGR) United States $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.194B 0.00
EnGene Holdings (ENGN) Canada $0.193B 0.00
Nuvectis Pharma (NVCT) United States $0.185B 0.00
Puma Biotechnology (PBYI) United States $0.185B 4.83
Eledon Pharmaceuticals (ELDN) United States $0.184B 0.00
Fate Therapeutics (FATE) United States $0.183B 0.00
DiaMedica Therapeutics (DMAC) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.176B 0.00
INmune Bio (INMB) United States $0.175B 0.00
Ventyx Biosciences (VTYX) United States $0.175B 0.00
Sagimet Biosciences (SGMT) United States $0.171B 0.00
Alumis (ALMS) United States $0.170B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.167B 0.00
Neumora Therapeutics (NMRA) United States $0.165B 0.00
Agenus (AGEN) United States $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.163B 0.00
Galena Biopharma (SLS) United States $0.161B 0.00
Editas Medicine (EDIT) United States $0.160B 0.00
BioAge Labs (BIOA) United States $0.160B 0.00
Compugen (CGEN) Israel $0.155B 0.00
Rapt Therapeutics (RAPT) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.153B 0.00
23andMe Holding (MEHCQ) United States $0.152B 0.00
Alpha Cognition (ACOG) Canada $0.150B 0.00
Alector (ALEC) United States $0.149B 0.00
Black Diamond Therapeutics (BDTX) United States $0.147B 43.00
Kyverna Therapeutics (KYTX) United States $0.147B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.141B 0.00
Spero Therapeutics (SPRO) United States $0.140B 0.00
Nkarta (NKTX) United States $0.135B 0.00
Seer (SEER) United States $0.134B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.127B 0.00
Cabaletta Bio (CABA) United States $0.126B 0.00
Elicio Therapeutics (ELTX) United States $0.125B 0.00
Sangamo Therapeutics (SGMO) United States $0.124B 0.00
Contineum Therapeutics (CTNM) United States $0.123B 0.00
C4 Therapeutics (CCCC) United States $0.123B 0.00
TuHURA Biosciences (HURA) United States $0.123B 0.00
Invivyd (IVVD) United States $0.119B 0.00
Theratechnologies (THTX) Canada $0.119B 0.00
Caribou Biosciences (CRBU) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.114B 0.00
EXoZymes (EXOZ) United States $0.112B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.109B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.109B 0.00
IO Biotech (IOBT) Denmark $0.105B 0.00
Tenaya Therapeutics (TNYA) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.102B 0.00
Senti Biosciences (SNTI) United States $0.100B 0.00
Pliant Therapeutics (PLRX) United States $0.100B 0.00
HilleVax (HLVX) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Nautilus Biotechnology (NAUT) United States $0.097B 0.00
Genelux (GNLX) United States $0.097B 0.00
Coherus BioSciences (CHRS) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.094B 0.00
Climb Bio (CLYM) United States $0.094B 0.00
Adagene (ADAG) China $0.094B 0.00
Biomea Fusion (BMEA) United States $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Jasper Therapeutics (JSPR) United States $0.090B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.089B 0.00
XBiotech (XBIT) United States $0.088B 0.00
Whitehawk Therapeutics (WHWK) United States $0.088B 0.00
Zura Bio (ZURA) United States $0.086B 0.00
Inovio Pharmaceuticals (INO) United States $0.083B 0.00
IGM Biosciences (IGMS) United States $0.079B 0.00
Cellectis S.A (CLLS) France $0.078B 0.00
Elutia (ELUT) United States $0.078B 0.00
PDS Biotechnology (PDSB) United States $0.077B 0.00
Immuneering (IMRX) United States $0.077B 0.00
Immunic (IMUX) United States $0.076B 0.00
Skye Bioscience (SKYE) United States $0.075B 0.00
Citius Oncology (CTOR) United States $0.075B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.075B 0.00
TELA Bio (TELA) United States $0.075B 0.00
Forte Biosciences (FBRX) United States $0.075B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.073B 0.00
Seres Therapeutics (MCRB) United States $0.072B 0.00
Sutro Biopharma (STRO) United States $0.072B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
MediciNova (MNOV) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Ikena Oncology (IKNA) United States $0.069B 0.00
Exicure (XCUR) United States $0.068B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Immix Biopharma (IMMX) United States $0.066B 0.00
ZIVO Bioscience (ZIVO) United States $0.066B 0.00
OKYO Pharma (OKYO) $0.064B 0.00
Oncobiologics (OTLK) United States $0.064B 0.00
Werewolf Therapeutics (HOWL) United States $0.064B 0.00
Repare Therapeutics (RPTX) Canada $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
Annovis Bio (ANVS) United States $0.063B 0.00
Opus Genetics (IRD) United States $0.062B 0.00
Kalaris Therapeutics (KLRS) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Adlai Nortye (ANL) Cayman Islands $0.061B 0.00
Precision BioSciences (DTIL) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Adverum Biotechnologies (ADVM) United States $0.059B 0.00
Akoya Biosciences (AKYA) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.055B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
Quince Therapeutics (QNCX) United States $0.053B 0.00
Renovaro (RENB) United States $0.053B 0.00
Applied Therapeutics (APLT) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.051B 0.00
Celularity (CELU) United States $0.050B 0.00
PepGen (PEPG) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Mersana Therapeutics (MRSN) United States $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Connect Biopharma Holdings (CNTB) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.042B 0.00
Quantum Biopharma (QNTM) Canada $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
CAMP4 Therapeutics (CAMP) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Clene (CLNN) United States $0.038B 0.00
Medicus Pharma (MDCX) United States $0.037B 0.00
Pluri (PLUR) Israel $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
FibroBiologics (FBLG) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.031B 0.00
Oncolytics Biotech (ONCY) Canada $0.031B 0.00
ALX Oncology Holdings (ALXO) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
Generation Bio (GBIO) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
BioAtla (BCAB) United States $0.028B 0.00
Vor Biopharma (VOR) $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Passage Bio (PASG) United States $0.026B 0.00
ABVC BioPharma (ABVC) United States $0.026B 0.00
Imunon (IMNN) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
X4 Pharmaceuticals (XFOR) United States $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.024B 0.00
CalciMedica (CALC) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.023B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.022B 0.00
Femasys (FEMY) United States $0.020B 0.00
Advanced Biomed (ADVB) United States $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Elevation Oncology (ELEV) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
Longeveron (LGVN) United States $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Rallybio (RLYB) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Eyenovia (EYEN) United States $0.014B 0.00
Athira Pharma (ATHA) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
HCW Biologics (HCWB) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00